Given the reciprocal activity of BRD4 with the YAP/TAZ complex, dual BRD4 and YAP/TAZ inhibition could potentially enhance therapeutic efficacy with respect to mechanosignaling‐associated properties of tumour cells. The gene discussed is YAP1; the disease is neoplasm.